Metformin Affects the Transcriptomic Profile of Chicken Ovarian Cancer Cells

Ovarian cancer is the most lethal gynecological malignancy in women. Metformin intake is associated with a reduced incidence of ovarian cancer and increased overall survival rate. We determined the effect of metformin on sphere formation, extracellular matrix invasion, and transcriptome profile of o...

Full description

Bibliographic Details
Main Authors:	Lalitha Gopalan, Aswathy Sebastian, Craig A. Praul, Istvan Albert, Ramesh Ramachandran
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Genes
Subjects:	transcriptomics ovarian cancer metformin animal models
Online Access:	https://www.mdpi.com/2073-4425/13/1/30

Similar Items

Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer
by: Santosh Kumar Singh, et al.
Published: (2021-08-01)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
by: Marzieh Farimani Sanoee, et al.
Published: (2011-06-01)

Laparoscopic Ovarian Drilling in Metformin and Clomiphene Resistant Women with Polycystic Ovarian Syndrome
by: Soheila Arefi, et al.
Published: (2008-03-01)

Metformin and phenethyl isothiocyanate combined treatment <it>in vitro</it> is cytotoxic to ovarian cancer cultures
by: Chan Daniel K, et al.
Published: (2012-07-01)

Antitumor Effect of Metformin on Ovarian Cancer Cells
by: YU Hui, et al.
Published: (2024-01-01)

Comparison of Metformin and Orlistat in Anovulatory, Overweight and Obese Women with Polycystic Ovarian Syndrome
by: Uzma Gul, et al.
Published: (2023-06-01)

Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?
by: Mohsen Gharakhani, et al.
Published: (2011-07-01)

Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines
by: Patrycja Gralewska, et al.
Published: (2021-09-01)

Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
by: Sevgi Ayhan, et al.
Published: (2023-09-01)

Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
by: Giovanni Tossetta
Published: (2022-10-01)

Effect of metformin on insulin levels, blood sugar, and body mass index in polycystic ovarian syndrome cases
by: Nidhi Sharma, et al.
Published: (2019-01-01)

Comparison of Therapeutic Effects in terms of Menstrual Irregularities between Statins and Metformin in Unmarried Patients with Polycystic Ovarian Syndrome
by: Sobia Nawaz, et al.
Published: (2023-08-01)

Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer
by: Ignacio Alfaro, et al.
Published: (2023-10-01)

Effect of metformin on apoptosis induction in ovarian cancer cells
by: Aneta Rogalska, et al.
Published: (2014-06-01)

Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells
by: Maritza P. Garrido, et al.
Published: (2020-10-01)

Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation
by: Sabatini Mary E, et al.
Published: (2011-05-01)

Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells
by: Leila Faramarzi, et al.
Published: (2019-12-01)

Transcriptome Analysis of Liver Cancer Cell Huh-7 Treated With Metformin
by: Chun-Qing Li, et al.
Published: (2022-03-01)

Possible Role of Metformin as an Immune Modulator in the Tumor Microenvironment of Ovarian Cancer
by: Faye K. Tsogas, et al.
Published: (2021-01-01)

Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication
by: Jielin Ouyang, et al.
Published: (2023-12-01)

Observational Studies on the Association Between Post-diagnostic Metformin Use and Survival in Ovarian Cancer: A Systematic Review and Meta-Analysis
by: Ting-Ting Gong, et al.
Published: (2019-05-01)

Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI
by: Mohammad Hossein Fallahzadeh, et al.
Published: (2011-01-01)

Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian Cancer
by: Sarah E. Taylor, et al.
Published: (2022-05-01)

Metformin reduces ovarian ischemia reperfusion injury in rats by improving oxidative/nitrosative stress
by: Mustafa Demir, et al.
Published: (2021-01-01)

Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
by: Mary P. Udumula, et al.
Published: (2022-03-01)

The effects of melatonin and metformin on histological characteristics of the ovary and uterus in letrozole-induced polycystic ovarian syndrome mice: A stereological study
by: Parvin Lohrasbi, et al.
Published: (2022-11-01)

A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome
by: Yogesh Kumar, et al.
Published: (2018-01-01)

N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome
by: Ebrahim Cheraghi, et al.
Published: (2018-01-01)

Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer
by: Jerry Vriend, et al.
Published: (2021-05-01)

Metformin Treatment Modulates Long Non-Coding RNA Isoforms Expression in Human Cells
by: Izabela Mamede C. A. da Conceição, et al.
Published: (2022-10-01)

Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates
by: Pratap Kumar, et al.
Published: (2014-01-01)

Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways
by: Liwei Ma, et al.
Published: (2019-02-01)

Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
by: Kuo-Chang Wen, et al.
Published: (2020-08-01)

Exploiting the Warburg Effect: Co‐Delivery of Metformin and FOXK2 siRNA for Ovarian Cancer Therapy
by: Wenhui Zhou, et al.
Published: (2024-03-01)

Omentum provides a special cell microenvironment for ovarian cancer
by: Zeying Li, et al.
Published: (2023-10-01)

The effect of metformin on clinical features of women with polycystic ovary syndrome
by: Bilibajkić Miljanja, et al.
Published: (2018-01-01)

Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
by: Elina Urpilainen, et al.
Published: (2018-07-01)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
by: Sandra Muñoz-Galván, et al.
Published: (2021-08-01)

Transcriptome Analysis of Ovarian Follicles Reveals Potential Pivotal Genes Associated With Increased and Decreased Rates of Chicken Egg Production
by: Xiaoxia Chen, et al.
Published: (2021-03-01)

Transcriptomic profile of premature ovarian insufficiency with RNA-sequencing
by: Jiaman Wu, et al.
Published: (2024-04-01)